RxDoctor Payments Data

Michael Sension, MD

Internal Medicine · Fort Lauderdale, FLNPI 1790749661

Payments from drug & device makers

$1,017,681in general payments, 2019–2025

Across 1,776 payments — averaging $573.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$505K
  • Gilead$448K
  • Janssen Scientific Affairs, LLC$29K
  • Janssen Products, LP$20K
  • Merck$12K
  • GSK$1K
  • plus $3K from 11 others

What the payments were for

  • Consulting fees$45,7055%
  • Speaking & faculty fees$761,48075%
  • Grants$28,6403%
  • Travel & lodging$125,80212%
  • Food & beverage$48,3115%
  • Education$900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company783$504,896
Gilead807$447,844
Janssen Scientific Affairs, LLC16$28,953
Janssen Products, LP27$19,963
Merck54$11,715
GSK11$1,193
Theratechnologies Inc.13$1,151
EMD Serono, Inc.22$664
AbbVie(2 entities)11$455
Johnson & Johnson22$368
Napo Pharmaceuticals Inc2$147
Mylan Specialty L.p.1$125
Myocardial Solutions, Inc.1$89
Pfizer2$53
Amgen2$28
Vyera Pharmaceuticals, LLC1$20
Halozyme Inc1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,017,681 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Medicare billing

Part B allowed, 2024
$43,799
Medicare patients
74
Services billed
1,217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala825$3,214,209
SerostimSomatropin12$578,309
DovatoDolutegravir Sodium/Lamivudine122$366,992
RukobiaFostemsavir Tromethamine32$292,981
JulucaDolutegravir/Rilpivirine64$215,272
OdefseyEmtricitab/Rilpiviri/Tenof Ala54$188,550
TivicayDolutegravir Sodium70$181,252
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf40$169,292
PrezcobixDarunavir/Cobicistat64$151,881
Egrifta SvTesamorelin Acetate14$103,689
PifeltroDoravirine48$84,612
CabenuvaCabotegravir/Rilpivirine12$77,872
IsentressRaltegravir Potassium37$67,089
MounjaroTirzepatide40$40,454
DescovyEmtricitabine/Tenofov Alafenam12$25,845

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GileadBiktarvy, Descovy, Vemlidy$447,844$3,254,659848 claims
Viiv Healthcare CompanyDovato, Rukobia, Juluca, Tivicay, Cabenuva$504,896$1,134,369300 claims
EMD Serono, Inc.Serostim$664$578,30912 claims
Janssen Products, LPSymtuza$19,963$169,29240 claims
MerckPifeltro, Isentress, Belsomra, Janumet$11,715$166,096123 claims
Johnson & JohnsonPrezcobix, Xarelto$368$163,10182 claims
Theratechnologies Inc.Egrifta Sv$1,151$103,68914 claims
PfizerLyrica, Eliquis$53$18,61926 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,530 internal medicine providers in Florida.

Other internal medicine in Fort Lauderdale

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →